Pharmacy News

Image description

FDA approves Adlyxin to treat type 2 diabetes

The U.S. Food and Drug Administration has approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes.